How far has the stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) come to trade at their current price of $10.12, which gives it a market cap of $1.63B.
To trade now at $10.12, the stock has emerged from a 52-week low of $-22.45%. But the current price also compares with the 52-week peak of $-56.83%.
The stock’s journey to the current price can be understood by looking at its performance from the last week down to the 12 months. The stock?s weekly performance stands at -35.50% and its monthly performance is -29.87%. For the quarter, the stock has moved -39.98% and for half-year it has shifted -32.62%. So far this year the stock has moved -24.53% and for the last 12 months it has moved -37.45%.
Studying simple moving averages also tell the stock?s journey thus far. The 20-Day Simple Moving Average is $-33.79%, the 50-Day Simple Moving Average is $-33.50%, while the 200-Day Simple Moving Average is $-42.52%.
The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction. Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.
In terms of financial performance, Horizon Pharma Public Limited Company reported gross margin of 59.90% for the trailing 12 months and operating margin of -15.00% for the same period. Net profit margin was booked at -17.00%. With that, Horizon Pharma Public Limited Company posted EPS of $-1.04.
Horizon Pharma Public Limited Company’s P/Cash for the most recent quarter is 3.21, while P/Free Cash Flow for the trailing 12 months is 4.62. For perspective, payout ratio provides insight into a company’s ability to sustain dividend distributions. As such, a lower payout ratio is preferred to a higher payout ratio is it implies a company is preserving more cash for investments and other needs that it releases to shareholders.
EPS growth this year is expected to be -509.50% and Forward P/E is calculated to 3.88.